Propofol for palliative sedation.

BMJ Support Palliat Care 2020 Mar 5;10(1):4-6. Epub 2019 Sep 5.

Department of Palliative and Supportive Care, Cabrini Health, Melbourne, Victoria, Australia.

Palliative sedation is the intentional use of sedatives to manage refractory symptom(s), such as pain and/or terminal restlessness. This case report describes the successful use of propofol, an ultra-fast-acting anaesthetic agent commonly used for anaesthesia induction and maintenance to manage refractory agitated delirium in an acute inpatient palliative medicine setting.

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjspcare-2019-001899DOI Listing
March 2020

Publication Analysis

Top Keywords

palliative sedation
8
manage refractory
8
agitated delirium
4
report describes
4
case report
4
delirium acute
4
anaesthesia induction
4
terminal restlessness
4
describes successful
4
restlessness case
4
propofol ultra-fast-acting
4
agent commonly
4
induction maintenance
4
commonly anaesthesia
4
maintenance manage
4
anaesthetic agent
4
acute inpatient
4
refractory agitated
4
ultra-fast-acting anaesthetic
4
successful propofol
4

Similar Publications